查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1236107

鼻咽癌全球市场规模研究和预测，按治疗（化疗、免疫疗法、放疗等），按最终用户（医院/诊所、门诊手术中心、其他最终用户），区域分析，2022 -2029

Global Nasopharyngeal Cancer Market Size study & Forecast, by Therapy (Chemotherapy, Immunotherapy, Radiation Therapy, and Others), by End-User (Hospitals and Clinics, Ambulatory Surgery Centers, and Other End-Users), and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

鼻咽癌是头颈癌之一，感染风险高于其他患者。

这是一种在鼻咽组织中形成恶性癌细胞的疾病。 鼻咽癌市场在癌症发病率上升、诊疗意识提高等因素的推动下不断扩大。

根据国际世界癌症研究基金会 (WCRF) 更新至 2022 年的数据，鼻咽癌是全球最常见的癌症，在女性癌症中排名第 22 位，在男性癌症中排名第 18 位。 据 WCRF 称，到 2020 年，全球将诊断出约 133,000 例鼻咽癌新病例。 另一方面，增加政府在公共卫生保健方面的支出、增加临床试验和癌症研究活动正在市场上创造有利可图的机会。 然而，不断上升的治疗成本将阻碍整个 2022-2029 年预测期内的市场增长。

全球鼻咽癌市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于研发支出增加和与临床试验相关的产品批准增加，亚太地区在收入方面占据市场主导地位。 由于鼻咽癌患病率上升和预测期内市场参与者的战略举措等因素，预计亚太地区在预测期内将以最高复合年增长率增长。

近期市场趋势

  • 2022 年 2 月，在印度加尔各答，KMC 诊所开始在头颈科进行癌症筛查，包括鼻咽癌。 该筛查计划是与印度医学协会 (IMA)、印度牙科协会 (IDA) 和 Medica 超级专科医院合作开发的。 它将在 KMC 的所有 16 个中心实施。
  • 2022 年 1 月，Wistar 研究所宣布了口服抑製剂 VK-2019 在晚期 EB 病毒阳性鼻咽癌和淋巴瘤（一种罕见的头颈癌）患者中的安全性。一项旨在调查的 2 期研究疗效和有效性已经启动。 斯坦福大学医学院的研究人员正在领导这项研究。

全球鼻咽癌市场报告范围

  • 历史数据：2019-2020-2021
  • 估算基准年：2021 年
  • 预测期：2022-2029
  • 报告范围：收入预测、公司排名、竞争格局、增长因素、趋势
  • 按地区划分：北美、欧洲、亚太地区、拉丁美洲、世界其他地区
  • 定制范围：免费报告定制（最多 8 个工作小时）。 按国家、地区和部门划分的范围的添加和更改。

本研究的目的是弄清近年来各个领域和国家的市场规模，并对未来几年的市场规模进行预测。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还结合了利益相关者投资的潜在微观市场机会，以及主要参与者的竞争格局等详细分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 2019-2029 年按地区划分的鼻咽癌市场
    • 2019-2029 年按治疗分类的鼻咽癌市场
    • 鼻咽癌市场，按最终用户分类，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章鼻咽癌全球市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第三章鼻咽癌全球市场动态

  • 鼻咽癌市场影响分析（2019-2029）
    • 市场驱动因素
      • 癌症患病率上升
      • 提高诊断和治疗意识
    • 市场挑战
      • 治疗费用高
    • 市场机会
      • 增加政府在公共医疗保健方面的支出
      • 临床试验和癌症研究活动的增长

第 4 章鼻咽癌全球市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 最佳投资机会
  • 关键成功策略
  • 业内人士的前景
  • 分析师的建议和结论

第 5 章风险评估 COVID-19 影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球鼻咽癌市场：按治疗分类

  • 市场概况
  • 全球鼻咽癌市场：按治疗、按表现 - 潜力分析
  • 2019-2029 年按治疗方法分类的鼻咽癌全球市场估计和预测
  • 鼻咽癌市场，按细分市场分析
    • 化疗
    • 免疫疗法
    • 放射治疗
    • 其他

第 7 章全球鼻咽癌市场：按最终用户分类

  • 市场概况
  • 全球鼻咽癌市场：按最终用户分类），性能潜力分析
  • 2019-2029 年最终用户对鼻咽癌全球市场的估计和预测
  • 鼻咽癌市场，按细分市场分析
    • 医院和诊所
    • 门诊手术中心
    • 其他最终用户

第 8 章全球鼻咽癌市场：区域分析

  • 鼻咽癌市场，按地区划分的市场概况
  • 北美
    • 美国
      • 按疗法估算和预测，2019-2029 年
      • 2019-2029 年最终用户的估计和预测
    • 加拿大
  • 欧洲鼻咽癌市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区鼻咽癌市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲鼻咽癌市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地区

第 9 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 百康有限公司
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概览
      • 近期趋势
    • Bristol Myers Squibb Company
    • Cyclacel Pharmaceuticals
    • F. Hoffman La-Roche Ltd
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • GSK plc.
    • Sanofi
    • Theravectys SA

第 10 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

The global Nasopharyngeal Cancer Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Nasopharyngeal Cancer is a head and neck cancer that possesses a risk of infection than other patients. It is a disease in which malignant cancer cells are formed in the tissues of the nasopharynx. The Nasopharyngeal Cancer market is expanding because of factors such as the rising prevalence of cancer diseases and increasing awareness towards diagnosis and treatment.

According to World Cancer Research Fund International (WCRF) data updated in 2022, NPC is the 22nd most common cancer in the world, ranking 22nd among cancers in women and 18th among cancers in men. According to the WCRF, approximately 133,000 new NPC cases will be diagnosed globally in 2020. Whereas rising government spending on public healthcare and growing clinical trials & cancer research activities create lucrative opportunities for the market. However, higher treatment costs hamper the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Nasopharyngeal Cancer Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia Pacific dominated the market in terms of revenue, owing to the increasing research and development expenditure, and growing product approvals associated with clinical trials. Whereas the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing prevalence of nasopharyngeal cancer and strategic initiatives by market players in the forecast period

Major market players included in this report are:

  • Biocon Limited
  • Bristol Myers Squibb Company
  • Cyclacel Pharmaceuticals
  • F. Hoffman La-Roche Ltd
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • GSK plc.
  • Sanofi
  • Theravectys SA

Recent Developments in the Market:

  • In February 2022, In Kolkata, India, KMC clinics began cancer screening, including nasopharyngeal cancer under the head and neck division. The screening program was developed in partnership with the Indian Medical Association (IMA), the Indian Dental Association (IDA), and Medica Super specialty Hospital. It is expected to be carried out at all 16 KMC centers
  • In January 2022, The Wistar Institute initiated a phase 2 trial to investigate the safety and efficacy of the oral inhibitor VK-2019 in patients with advanced Epstein-Barr Virus-positive nasopharyngeal carcinoma, a rare type of head and neck cancer, and lymphoma. Stanford University School of Medicine researchers are leading the trial.

Global Nasopharyngeal Cancer Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Therapy, End-user, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy
  • Others

By End-user:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Other End-users

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Nasopharyngeal Cancer Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Nasopharyngeal Cancer Market, by Therapy, 2019-2029 (USD Billion)
    • 1.2.3. Nasopharyngeal Cancer Market, by End-User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Nasopharyngeal Cancer Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Nasopharyngeal Cancer Market Dynamics

  • 3.1. Nasopharyngeal Cancer Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of cancer diseases
      • 3.1.1.2. Increasing awareness toward diagnosis and treatment
    • 3.1.2. Market Challenges
      • 3.1.2.1. Higher treatment cost
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising government spending toward public healthcare
      • 3.1.3.2. Growing clinical trials and cancer research activities

Chapter 4. Global Nasopharyngeal Cancer Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Nasopharyngeal Cancer Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Nasopharyngeal Cancer Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Nasopharyngeal Cancer Market Estimates & Forecasts by Therapy 2019-2029 (USD Billion)
  • 6.4. Nasopharyngeal Cancer Market, Sub-Segment Analysis
    • 6.4.1. Chemotherapy
    • 6.4.2. Immunotherapy
    • 6.4.3. Radiation Therapy
    • 6.4.4. Others

Chapter 7. Global Nasopharyngeal Cancer Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Nasopharyngeal Cancer Market by End-User, Performance - Potential Analysis
  • 7.3. Global Nasopharyngeal Cancer Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
  • 7.4. Nasopharyngeal Cancer Market, Sub-Segment Analysis
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Surgery Centers
    • 7.4.3. Other End-users

Chapter 8. Global Nasopharyngeal Cancer Market, Regional Analysis

  • 8.1. Nasopharyngeal Cancer Market, Regional Market Snapshot
  • 8.2. North America Nasopharyngeal Cancer Market
    • 8.2.1. U.S. Nasopharyngeal Cancer Market
      • 8.2.1.1. Therapy breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-User breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Nasopharyngeal Cancer Market
  • 8.3. Europe Nasopharyngeal Cancer Market Snapshot
    • 8.3.1. U.K. Nasopharyngeal Cancer Market
    • 8.3.2. Germany Nasopharyngeal Cancer Market
    • 8.3.3. France Nasopharyngeal Cancer Market
    • 8.3.4. Spain Nasopharyngeal Cancer Market
    • 8.3.5. Italy Nasopharyngeal Cancer Market
    • 8.3.6. Rest of Europe Nasopharyngeal Cancer Market
  • 8.4. Asia-Pacific Nasopharyngeal Cancer Market Snapshot
    • 8.4.1. China Nasopharyngeal Cancer Market
    • 8.4.2. India Nasopharyngeal Cancer Market
    • 8.4.3. Japan Nasopharyngeal Cancer Market
    • 8.4.4. Australia Nasopharyngeal Cancer Market
    • 8.4.5. South Korea Nasopharyngeal Cancer Market
    • 8.4.6. Rest of Asia Pacific Nasopharyngeal Cancer Market
  • 8.5. Latin America Nasopharyngeal Cancer Market Snapshot
    • 8.5.1. Brazil Nasopharyngeal Cancer Market
    • 8.5.2. Mexico Nasopharyngeal Cancer Market
    • 8.5.3. Rest of Latin America Nasopharyngeal Cancer Market
  • 8.6. Rest of The World Nasopharyngeal Cancer Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Biocon Limited
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Bristol Myers Squibb Company
    • 9.2.3. Cyclacel Pharmaceuticals
    • 9.2.4. F. Hoffman La-Roche Ltd
    • 9.2.5. Merck & Co., Inc.
    • 9.2.6. Novartis AG
    • 9.2.7. Pfizer, Inc.
    • 9.2.8. GSK plc.
    • 9.2.9. Sanofi
    • 9.2.10. Theravectys SA

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Nasopharyngeal Cancer Market, report scope
  • TABLE 2. Global Nasopharyngeal Cancer Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Nasopharyngeal Cancer Market estimates & forecasts by Therapy 2019-2029 (USD Billion)
  • TABLE 4. Global Nasopharyngeal Cancer Market estimates & forecasts by End-User 2019-2029 (USD Billion)
  • TABLE 5. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Nasopharyngeal Cancer Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Nasopharyngeal Cancer Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Nasopharyngeal Cancer Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Nasopharyngeal Cancer Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Nasopharyngeal Cancer Market
  • TABLE 70. List of primary sources, used in the study of global Nasopharyngeal Cancer Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Nasopharyngeal Cancer Market, research methodology
  • FIG 2. Global Nasopharyngeal Cancer Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Nasopharyngeal Cancer Market, key trends 2021
  • FIG 5. Global Nasopharyngeal Cancer Market, growth prospects 2022-2029
  • FIG 6. Global Nasopharyngeal Cancer Market, porters 5 force model
  • FIG 7. Global Nasopharyngeal Cancer Market, pest analysis
  • FIG 8. Global Nasopharyngeal Cancer Market, value chain analysis
  • FIG 9. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Nasopharyngeal Cancer Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Nasopharyngeal Cancer Market, regional snapshot 2019 & 2029
  • FIG 15. North America Nasopharyngeal Cancer Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Nasopharyngeal Cancer Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Nasopharyngeal Cancer Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Nasopharyngeal Cancer Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Nasopharyngeal Cancer Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable